Location History:
- 117610 Singapore, SG (2009)
- Singapore, SG (2017 - 2021)
Company Filing History:
Years Active: 2009-2021
Title: **Innovative Contributions of Chee Mun Kuan in Biotechnology**
Introduction
Chee Mun Kuan is an inventive mind based in Singapore, known for his significant contributions to the field of biotechnology. With a count of three patents to his name, he has developed innovative solutions that enhance biological processes and sample analysis.
Latest Patents
His latest patents include the "Mixing Element for Container Assemblies," which addresses the efficiency of mixing substances within containers. This invention features a first mixing element that can create a vortex when the container rotates, ensuring optimal mixing of various substances used for injections or biological sample analysis.
Another noteworthy patent is the "Microfluidic Platform for Investigating Cell-Based Interactions." This platform employs a chip base made from specialized plastics with unique optical properties. It includes multiple ports that facilitate fluid communication with microfluidic channels, allowing for better handling of culture mediums in which cells are maintained. The innovative design improves the fluid's aspiration process, offering a significant advantage in biological research.
Career Highlights
Chee Mun Kuan has worked with several prestigious organizations throughout his career, including Becton Dickinson and Company Limited and Aim Biotech Pte. Ltd. His experiences in these prominent companies have been instrumental in shaping his research and inventions.
Collaborations
Throughout his journey, Chee has collaborated with esteemed colleagues such as Andrea Pavesi and Sei Hien Lim. These partnerships have not only enriched his projects but also contributed to advancements in the field of cell-based technology.
Conclusion
Chee Mun Kuan continues to push the boundaries of innovation in biotechnology with his inventive spirit and dedicated research. His contributions through valuable patents reflect his commitment to enhancing biological processes, ultimately benefiting the scientific community and beyond.